Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI).

Caplice NM, DeVoe MC, Choi J, Dahly D, Murphy T, Spitzer E, Van Geuns R, Maher MM, Tuite D, Kerins DM, Ali MT, Kalyar I, Fahy EF, Khider W, Kelly P, Kearney PP, Curtin RJ, O'Shea C, Vaughan CJ, Eustace JA, McFadden EP.

Am Heart J. 2018 Jun;200:110-117. doi: 10.1016/j.ahj.2018.03.018. Epub 2018 Apr 3.

PMID:
29898838
2.

The PHARMS (Patient Held Active Record of Medication Status) feasibility study: a research proposal.

Walsh E, Sahm LJ, Kearney PM, Smithson H, Kerins DM, Ngwa C, Fitzgerald C, Mc Carthy S, Connolly E, Dalton K, Byrne D, Carey M, Bradley C.

BMC Res Notes. 2018 Jan 8;11(1):6. doi: 10.1186/s13104-017-3118-3.

3.

The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agent.

McCarthy CP, Mullins KV, Kerins DM.

Eur Heart J Cardiovasc Pharmacother. 2016 Oct;2(4):266-72. doi: 10.1093/ehjcvp/pvv051. Epub 2015 Dec 9. Review.

PMID:
27533944
4.

Cardiovascular safety of anti-diabetic drugs.

Kumar R, Kerins DM, Walther T.

Eur Heart J Cardiovasc Pharmacother. 2016 Jan;2(1):32-43. doi: 10.1093/ehjcvp/pvv035. Epub 2015 Sep 7. Review.

PMID:
27533060
5.

Trial of a novel plasma gas disinfection system (Radica) to reduce mattress residual bacterial contamination in the acute hospital setting: a preliminary study.

Shiely F, Fallon D, Casey C, Kerins DM, Eustace JA.

Ir J Med Sci. 2017 Feb;186(1):17-21. doi: 10.1007/s11845-016-1400-3. Epub 2016 Jan 21.

PMID:
26797777
6.

Exercise and associated dietary extremes impact on gut microbial diversity.

Clarke SF, Murphy EF, O'Sullivan O, Lucey AJ, Humphreys M, Hogan A, Hayes P, O'Reilly M, Jeffery IB, Wood-Martin R, Kerins DM, Quigley E, Ross RP, O'Toole PW, Molloy MG, Falvey E, Shanahan F, Cotter PD.

Gut. 2014 Dec;63(12):1913-20. doi: 10.1136/gutjnl-2013-306541. Epub 2014 Jun 9.

PMID:
25021423
7.

Effects of centrally acting angiotensin converting enzyme inhibitors on functional decline in patients with Alzheimer's disease.

O'Caoimh R, Healy L, Gao Y, Svendrovski A, Kerins DM, Eustace J, Kehoe PG, Guyatt G, Molloy DW.

J Alzheimers Dis. 2014;40(3):595-603. doi: 10.3233/JAD-131694.

PMID:
24496072
8.

Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia.

Gao Y, O'Caoimh R, Healy L, Kerins DM, Eustace J, Guyatt G, Sammon D, Molloy DW.

BMJ Open. 2013 Jul 25;3(7). pii: e002881. doi: 10.1136/bmjopen-2013-002881. Print 2013.

9.

In vivo impact of prodrug isosorbide-5-nicotinate-2-aspirinate on lipids and prostaglandin D2: is this a new immediate-release therapeutic option for niacin?

Ledwidge MT, Ryan F, Kerins DM, O'Connell D, Cefali G, Harmon S, Jones M, Gilmer JF.

Atherosclerosis. 2012 Apr;221(2):478-83. doi: 10.1016/j.atherosclerosis.2012.01.016. Epub 2012 Jan 13.

PMID:
22326030
10.

Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine.

Kerins DM, Koury MJ, Capdevila A, Rana S, Wagner C.

Am J Clin Nutr. 2001 Dec;74(6):723-9.

PMID:
11722952
11.

Isolated Rheumatic Tricuspid Stenosis with Reverse Lutembacher's Physiology.

Fadel BM, Hiatt BL, Kerins DM.

Echocardiography. 1999 Aug;16(6):567-573.

PMID:
11175189
12.
13.

Liver regeneration is transiently impaired in urokinase-deficient mice.

Roselli HT, Su M, Washington K, Kerins DM, Vaughan DE, Russell WE.

Am J Physiol. 1998 Dec;275(6 Pt 1):G1472-9.

PMID:
9843786
15.

Diagnosing left ventricular dysfunction after myocardial infarction: the Dundee algorithm.

Darbar D, Gillespie N, Choy AM, Lang CC, Pringle SD, Pringle TH, Kerins DM, McNeill GP, Struthers AD.

QJM. 1997 Nov;90(11):677-83.

PMID:
9474348
16.

Optimal Albunex dosing for enhancement of Doppler tricuspid regurgitation spectra.

Kemp WE Jr, Kerins DM, Shyr Y, Byrd BF 3rd.

Am J Cardiol. 1997 Jan 15;79(2):232-4.

PMID:
9193036
17.
18.

Doppler echocardiography in cardiac tamponade and constrictive pericarditis.

Zhang S, Kerins DM, Byrd BF 3rd.

Echocardiography. 1994 Sep;11(5):507-21. Review.

PMID:
10150627
19.

Role of the perfluorocarbon Fluosol-DA in coronary angioplasty.

Kerins DM.

Am J Med Sci. 1994 Mar;307(3):218-21. Review. No abstract available.

PMID:
8160713
20.

Pharmacokinetics of tissue-type plasminogen activator during acute myocardial infarction in men. Effect of a prostacyclin analogue.

Kerins DM, Roy L, Kunitada S, Adedoyin A, FitzGerald GA, Fitzgerald DJ.

Circulation. 1992 Feb;85(2):526-32. Erratum in: Circulation 1992 Aug;86(2):698.

PMID:
1370924
21.

Ampicillin/sulbactam--a combination of an old and a new agent in the treatment of infection.

Kerins DM.

Am J Med Sci. 1991 Jun;301(6):406-11. Review. No abstract available.

PMID:
2039029
22.

The current role of platelet-active drugs in ischaemic heart disease.

Kerins DM, FitzGerald GA.

Drugs. 1991 May;41(5):665-71. Review. No abstract available.

PMID:
1712703
23.

A prostacyclin analog impairs the response to tissue-type plasminogen activator during coronary thrombolysis: evidence for a pharmacokinetic interaction.

Kerins DM, Shuh M, Kunitada S, Fitzgerald GA, Fitzgerald DJ.

J Pharmacol Exp Ther. 1991 Apr;257(1):487-92.

PMID:
1708425
24.

Prostacyclin and prostaglandin E1: molecular mechanisms and therapeutic utility.

Kerins DM, Murray R, FitzGerald GA.

Prog Hemost Thromb. 1991;10:307-37. Review. No abstract available.

PMID:
1848945
25.

Platelet and vascular function during coronary thrombolysis with tissue-type plasminogen activator.

Kerins DM, Roy L, FitzGerald GA, Fitzgerald DJ.

Circulation. 1989 Dec;80(6):1718-25.

PMID:
2513144

Supplemental Content

Loading ...
Support Center